如何更好地预测COVID-19住院患者的肺血栓?
本文探讨COVID-19住院患者肺栓塞的预测问题,指出D-二聚体阈值2590 ng·mL−1可在临床恶化时预测肺栓塞,并强调疾病血管趋向性及肺血管内皮炎伴血栓形成和血管新生的机制。
要点
- D-二聚体阈值2590 ng·mL−1可在临床恶化时预测COVID-19患者肺栓塞
- COVID-19血管趋向性可能是主要病理途径
- 特定肺血管内皮炎与血栓形成和血管新生相关
核心结论
- D-二聚体阈值2590 ng·mL−1可在临床恶化时预测COVID-19患者肺栓塞
- COVID-19血管趋向性似乎是主要病理途径
主要发现
- 近期研究强调特定肺血管内皮炎与血栓形成和血管新生相关
- COVID-19血管趋向性似乎成为主要病理途径
关键数值与推荐
- D-二聚体阈值2590 ng·mL−1可在临床恶化时预测COVID-19患者肺栓塞
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
D-dimer threshold at 2590 ng·mL−1 is able to predict pulmonary embolism in COVID-19 patients with clinical deterioration https://bit.ly/3kYObc3 The emergence of coronavirus disease 2019 (COVID-19) has put pressure on health systems around the world [1, 2]. This coronavirus has also questioned much of our medical knowledge, with each day seeing the appearance of a new possible clinical expression of the virus [3]. Although its physiopathology is still poorly understood, the vascular tropism of the disease now seems to be a major pathway [4]. Recent studies highlight the development of a specific pulmonary vascular endothelialitis associated with thrombosis and angiogenesis [5].
引用
- Bertoletti L, Huisman MV. How can we better predict pulmonary blood clots in patients hospitalised for COVID-19? Eur Respir J. 2020. PMID: 32907888. doi:10.1183/13993003.03092-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。